Literature DB >> 7927233

Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog.

N R Pimstone1, R C Stadalnik, D R Vera, D P Hutak, W L Trudeau.   

Abstract

UNLABELLED: We have developed a quantitative functional imaging study of the liver using a radiolabeled asialoglycoprotein analog, Tc-galactosyl-neoglycoalbumin. Heart and liver time-activity data can be transformed by automated kinetic analysis into asialoglycoprotein hepatocyte receptor concentration. Twenty-eight healthy controls, 46 patients with noncholestatic chronic liver injury and 11 patients with primary biliary cirrhosis were studied. Liver function was also assessed by Pugh modified-Child-Turcotte criteria, 14C-aminopyrine breath test and indocyanine green clearance (24 patients).
RESULTS: (a) In normal controls with a Child-Turcotte criteria score of 5, receptor concentration ranged from 0.63 to 1.19 mumol/L, with a mean 0.83 +/- 2 S.D. 0.06 mumol/L, which was significantly higher (p < 0.001) than that of the patient group (mean receptor concentration = 0.44 +/- 2 S.D. 0.04 mumol/L). In cirrhotic patients with Child-Turcotte criteria score of 5, the mean receptor concentration was 0.60 +/- 2 S.D. 0.07 mumol/L, which was significantly lower than controls (p < 0.01). In end-stage cirrhosis (Child-Turcotte criteria score 11 to 15), a group in which patients died or required orthotopic liver transplantation within 1 yr, the mean receptor concentration was 0.35 +/- 2 S.D. to 0.07 mumol/L. The sensitivity and specificity for receptor concentration in relation to liver disease, with values above 0.65 mumol/L being normal, were 0.96 and 0.88, respectively. Receptor concentration correlated well with Child-Turcotte criteria score (r = 0.78, p = < 0.001), with aminopyrine breath test (r = 0.75, p = < 0.001) and with indocyanine green clearance (r = 0.88, p = < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927233     DOI: 10.1002/hep.1840200421

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

Review 1.  Non-invasive diagnosis of liver fibrosis and cirrhosis.

Authors:  Yoav Lurie; Muriel Webb; Ruth Cytter-Kuint; Shimon Shteingart; Gerardo Z Lederkremer
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

2.  Constant serum levels of secreted asialoglycoprotein receptor sH2a and decrease with cirrhosis.

Authors:  Ron Benyair; Maria Kondratyev; Elena Veselkin; Sandra Tolchinsky; Marina Shenkman; Yoav Lurie; Gerardo Z Lederkremer
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

3.  Capacity limits of asialoglycoprotein receptor-mediated liver targeting.

Authors:  Charlotte Bon; Thomas Hofer; Alain Bousquet-Mélou; Mark R Davies; Ben-Fillippo Krippendorff
Journal:  MAbs       Date:  2017-09-06       Impact factor: 5.857

4.  Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis.

Authors:  Norihiro Kokudo; David R Vera; Keiichiro Tada; Mitsuru Koizumi; Makoto Seki; Toshiki Matsubara; Hirotoshi Ohta; Toshiharu Yamaguchi; Takashi Takahashi; Toshifusa Nakajima; Tetsuichiro Muto
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

5.  Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve.

Authors:  Tohru Utsunomiya; Mitsuo Shimada; Jun Hanaoka; Mami Kanamoto; Tetsuya Ikemoto; Yuji Morine; Satoru Imura; Masafui Harada
Journal:  J Gastroenterol       Date:  2011-12-15       Impact factor: 7.527

6.  Preoperative assessment of congestive liver dysfunction using technetium-99 m galactosyl human serum albumin liver scintigraphy in patients with severe valvular heart disease.

Authors:  Hiroyuki Nishi; Toshiki Takahashi; Goro Matsumiya; Hiroshi Takano; Hajime Ichikawa; Shigeru Miyagawa; Yoshiki Sawa
Journal:  Surg Today       Date:  2007-06-26       Impact factor: 2.549

7.  A secreted form of the asialoglycoprotein receptor, sH2a, as a novel potential noninvasive marker for liver fibrosis.

Authors:  Elena Veselkin; Maria Kondratyev; Yoav Lurie; Efrat Ron; Moshe Santo; Shimon Reif; Irma Elashvili; Lana Bar; Gerardo Z Lederkremer
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

8.  PK/PD modeling of FXI antisense oligonucleotides to bridge the dose-FXI activity relation from healthy volunteers to end-stage renal disease patients.

Authors:  Stefan Willmann; Eleonora Marostica; Nelleke Snelder; Alexander Solms; Markus Jensen; Maximilian Lobmeyer; Anthonie W A Lensing; Claudette Bethune; Erin Morgan; Rosie Z Yu; Yanfeng Wang; Shiangtung W Jung; Richard Geary; Sanjay Bhanot
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.